Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ultrasound for Peripheral Nerve Modulation

NCT: NCT07572591 · NOT_YET_RECRUITING

NCT IDNCT07572591
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-06

Brief Summary

This study evaluates an ultrasound device designed to reduce pain by targeting peripheral nerves without surgery or medication. The device is placed on the skin over the area of pain and delivers controlled ultrasound stimulation. Adults with nerve-related pain will participate in a single study visit that includes stimulation sessions and pain assessments. The goal of this study is to determine whether non-invasive ultrasound can safely and effectively reduce pain and to assess whether this approach is practical for future clinical use.

Frequently Asked Questions

What is Ultrasound for Peripheral Nerve Modulation?

Ultrasound for Peripheral Nerve Modulation is a clinical trial registered under NCT07572591. Current status: NOT_YET_RECRUITING.

What is the status of NCT07572591?

The current status of NCT07572591 (Ultrasound for Peripheral Nerve Modulation) is: NOT_YET_RECRUITING.

When did Ultrasound for Peripheral Nerve Modulation start?

Ultrasound for Peripheral Nerve Modulation started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.